Daily-equity-report by Epicresearch 03 April 2013
-
Upload
gauri-ojha -
Category
Documents
-
view
218 -
download
0
Transcript of Daily-equity-report by Epicresearch 03 April 2013
-
7/28/2019 Daily-equity-report by Epicresearch 03 April 2013
1/4
-=6HEADLINES
Indian Market
Indian equity markets were up 0.77%
Nifty up by 43.70 pts and settle at5748.10
Sensex up by 176.20 pts at 19040.95
Bank Nifty up by 97.85 pts at 11523.40
Global Market
European markets were up with FTSE upby 66.91 closed at 6478 ,CAC up by42.87 closed at 3774 and DAX up 95.70closed at 7891.
Dow future was up by 62 closed at
14551.00
WWW.EPICRESEARCH.CO 09752199966
DAILY EQUITY
NEWSLETTER3
RDAPRIL 2013
HEADLINES
Slow growth to continue in April-June:
Bajaj Auto MD
Ramky Infra bags order of Rs 387cr,
stock up 13%
See no major impact of Basel III norms
on Biz: Canara Bank
CLSA upgrades Ambuja Cements to
buy; shares gain
-
7/28/2019 Daily-equity-report by Epicresearch 03 April 2013
2/4
FIIs and DIIs
CATEGORY DATE BUY SELL NET
FII 2-Apr-13 1979.52 2024.93 -45.41
DII 2-Apr-13 780.97 575.17 205.8
NIFTY DAILY PIVOTS
IVOT R4 R3 R2 R1 PP S1 S2 S3 S4
IFTY 5930 5863 5796 5772 5729 5705 5662 5595 5528
WWW.EPICRESEARCH.CO 09752199966
MARKETANALYSIS:
Key benchmark indices jumped as firm European markets boosted market sentiment. The barometerindex, the S&P BSE Sensex, scaled over 1-1/2 week high above the psychological 19,000 mark. The50 unit CNX Nifty also scaled its highest level in over 1-1/2 weeks. The Sensex was provisionally up
176.24 points or 0.93%, up about 215 points from the day's low and off close to 20 points from theday's high. Index heavyweight and cigarette maker ITC edged lower in choppy trade. Another index
heavyweight Reliance Industries (RIL) gained. The market breadth was strong. All the 13 sectoral
indices on BSE were in the green. Metal and bank stocks edged higher on renewed buying. Indianstocks gained for the fourth straight trading session today, 2 April 2013.
The market edged higher in early trade. The Sensex pared after hitting fresh intraday high in morningtrade. The. Shares of Reliance Communications (RCom) surged after Reliance Jlo Infocomm andReliance Communications today, 2 April 2013 announced the signing of a definitive agreement for
approx. Rs 1200 crore as one time indefeasible right to use (IRU) fees for sharing nationwide inter cityfiber optic network infrastructure.
S&P BSE Sensex was up 176.24 points or 0.93% to 19,040.99. The index rose 195.76 points at theday's high of 19,060.51 in late trade, its highest level since 21 March 2013.
The CNX Nifty was up 40.50 points or 0.71% to 5,744.90, as per provisional figures. The index hit ahigh of 5,754.60 in intraday trade, its highest level since 21 March 2013.
STOCKS TO WATCH
BAJAJ AUTO HERO MOTO
IDBI IDFC
SCRIPS IN BAN PERIOD
-
7/28/2019 Daily-equity-report by Epicresearch 03 April 2013
3/4
WWW.EPICRESEARCH.CO 09752199966
.
EXPERT OPINION
NIFTY
Nifty looks Bearish
Strategy: Sell on rise
Support:5700
Resistance: 5800
BANK NIFTY
Bank Nifty looks Bearish
Strategy: Sell on rise
Support:11460
Resistance:11600
460
GAINERSANDLOOSERS
PREVIOUSPERFORMANCE
TYPE SCRIP B/S RESULT
CASH CIPLA B TARGET HIT
CASH HEXAWARE B SL TRIGERRE
FUTURE IDBI BANK B TARGET HIT
FUTUREKARNATAKA
BANKB TARGET HIT
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHANG
E
Sun
Pharma851.30 1205.24 812.65 38.65 4.76
Reliance
Infra351.65 3226.57 338.75 12.90 3.81
Sesa Goa 156.90 2367.75 151.35 5.55 3.67
IDFC 147.00 4309.73 142.30 4.70 3.30
Cairn
India294.10 3144.53 286.05 8.05 2.81
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHAN
GE
Bajaj
Auto1752.70 471.39 1781.30 -28.60 -1.61
Asian
Paints4890.35 52.01 4954.95 -64.60 -1.30
Axis Bank 1301.35 1146.90 1314.90 -13.55 -1.03
HDFC 817.25 1303.04 825.20 -7.95 -0.96
Bharti
Airtel291.80 2705.43 293.65 -1.85 -0.63
-
7/28/2019 Daily-equity-report by Epicresearch 03 April 2013
4/4
6
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
ADANI ENT BUY 213.80 215.80 217.80 211.80
APOLLO TYRE BUY 87.00 88.00 89.00 86.00
FUTURE
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
AUROBINDO
PHARMABUY 158.50 160.50 162.50 156.50
DENA BANK BUY 95.20 96.20 97.20 94.20
DisclaimerThe information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved.Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.